About NeuroReserve
NeuroReserve is a private company based in Las Vegas, Nevada. It has reported $2,660,236 raised in five offerings on Form D since May 2019.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 24, 2025 | Apr 9, 2025 | $691,230fully sold | 5 | $138K | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Aug 31, 2022 | Sep 12, 2022amended Dec 4, 2023 | $1,384,006of $1.5M target | 34 | $40,706 | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Jul 15, 2021 | Sep 8, 2021 | $295,000of $350K target | 14 | $21,071 | Debt, OptionsRule 506(b) | Form D ↗ |
| Jul 22, 2020 | Aug 5, 2020 | $240,000of $475K target | 8 | $30,000 | Debt, OptionsRule 506(b) | Form D ↗ |
| Apr 30, 2019 | May 14, 2019 | $50,000of $125K target | 4 | $12,500 | Debt, OptionsRule 506(b) | Form D ↗ |
| Total, five offerings | $2,660,236 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on NeuroReserve's Form D filed Apr 9, 2025.

Edward Park
Founder and director
On every Form D that NeuroReserve has filed: 6 filings, from May 14, 2019 to Apr 9, 2025.
RN
Robert Newell
Director
First appears on the Form D that NeuroReserve filed on September 12, 2022; on 3 of its 6 filings.
